Anuh Pharma Statistics

Total Valuation

Anuh Pharma has a market cap or net worth of INR 10.56 billion. The enterprise value is 9.93 billion.

Market Cap	10.56B
Enterprise Value	9.93B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.11M
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.36%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	11.07M

Valuation Ratios

The trailing PE ratio is 22.30.

PE Ratio	22.30
Forward PE	n/a
PS Ratio	1.60
PB Ratio	3.24
P/TBV Ratio	3.24
P/FCF Ratio	62.19
P/OCF Ratio	28.44
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.31, with an EV/FCF ratio of 58.49.

EV / Earnings	20.97
EV / Sales	1.50
EV / EBITDA	16.31
EV / EBIT	19.04
EV / FCF	58.49

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.03.

Current Ratio	2.11
Quick Ratio	1.62
Debt / Equity	0.03
Debt / EBITDA	0.18
Debt / FCF	0.64
Interest Coverage	84.24

Financial Efficiency

Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 10.34%.

Return on Equity (ROE)	15.34%
Return on Assets (ROA)	6.85%
Return on Invested Capital (ROIC)	10.34%
Return on Capital Employed (ROCE)	15.90%
Revenue Per Employee	37.80M
Profits Per Employee	2.71M
Employee Count	175
Asset Turnover	1.39
Inventory Turnover	6.66

Taxes

In the past 12 months, Anuh Pharma has paid 136.53 million in taxes.

Income Tax	136.53M
Effective Tax Rate	22.38%

Stock Price Statistics

The stock price has decreased by -7.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.79%
50-Day Moving Average	195.56
200-Day Moving Average	194.19
Relative Strength Index (RSI)	55.87
Average Volume (20 Days)	12,551

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anuh Pharma had revenue of INR 6.62 billion and earned 473.52 million in profits. Earnings per share was 9.45.

Revenue	6.62B
Gross Profit	1.62B
Operating Income	521.69M
Pretax Income	610.05M
Net Income	473.52M
EBITDA	609.09M
EBIT	521.69M
Earnings Per Share (EPS)	9.45

Full Income Statement

Balance Sheet

The company has 735.93 million in cash and 108.86 million in debt, giving a net cash position of 627.06 million.

Cash & Cash Equivalents	735.93M
Total Debt	108.86M
Net Cash	627.06M
Net Cash Per Share	n/a
Equity (Book Value)	3.26B
Book Value Per Share	65.17
Working Capital	1.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 371.25 million and capital expenditures -201.46 million, giving a free cash flow of 169.79 million.

Operating Cash Flow	371.25M
Capital Expenditures	-201.46M
Free Cash Flow	169.79M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 24.51%, with operating and profit margins of 7.89% and 7.16%.

Gross Margin	24.51%
Operating Margin	7.89%
Pretax Margin	9.22%
Profit Margin	7.16%
EBITDA Margin	9.21%
EBIT Margin	7.89%
FCF Margin	2.57%

Dividends & Yields

Anuh Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	26.44%
Buyback Yield	0.01%
Shareholder Yield	n/a
Earnings Yield	4.48%
FCF Yield	1.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4